The Stakes Are High So Get It Right
CHMP Oral Explanations And FDA AdComs
Executive Summary
The stakes are extremely high for companies called before EU or US regulators and scientific experts to answer queries about their new drug applications at the later stages of the review process. Consultant Kate Dion highlights to In Vivo helpful tips for companies facing this daunting situation.